Gelteq Limited Ordinary Shares (GELS) vs Xenetic Biosciences, Inc. (XBIO)

A side-by-side comparison of Gelteq Limited Ordinary Shares and Xenetic Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Gelteq Limited Ordinary Shares logo
GELS
Gelteq Limited Ordinary Shares
$5M
$0.57HealthcareDelayed quote: Oct 6, 2026, 2:47 PM EDT
Xenetic Biosciences, Inc. logo
XBIO
Xenetic Biosciences, Inc.
$5M
$2.16HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT

Total return — GELS vs XBIO

growth of $100 · dividends reinvested · last 2y
GELS -81.5% (-57.0%/yr)XBIO -40.7% (-23.0%/yr)XBIO compounded faster over this window
50100150Start $10020252026$18$59
GELS XBIO

GELS vs XBIO: by the numbers

  • •GELS is the larger company ($5M vs $5M market cap).
  • •Both run net losses; XBIO's is the smaller (-75.90% vs -4011.86% net margin).

Metrics side by side

Valuation

MetricGELSXBIO
P/S ratioN/A1.51
P/B ratio0.550.81

Profitability

MetricGELSXBIO
Gross margin100.00%100.00%
Operating margin-3317.65%-95.23%
Net margin-4011.86%-75.90%
ROE-42.05%-40.76%
ROIC-27.41%-43.50%

Growth (annualized)

MetricGELSXBIO
Revenue CAGR (5Y)N/A34.31%
Total return CAGR (5Y)N/A-34.54%

Go deeper

Full GELS analysisFull XBIO analysisInteractive comparison tool

Dig into the metrics

Gelteq Limited Ordinary Shares ROEXenetic Biosciences ROEGelteq Limited Ordinary Shares operating marginXenetic Biosciences operating marginGelteq Limited Ordinary Shares revenue growthXenetic Biosciences revenue growthGelteq Limited Ordinary Shares free cash flowXenetic Biosciences free cash flow

Gelteq Limited Ordinary Shares & Xenetic Biosciences appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.